openPR Logo
Press release

The Death of 60/40: A Deep Dive with Reinhard Muller on Navigating "Inflation 2.0"

01-23-2026 12:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

The Death of 60/40: A Deep Dive with Reinhard Muller on Navigating

Image: https://www.abnewswire.com/upload/2026/01/45bd6994782a051e45a0e026e979a4ac.jpg

Discover how to protect your capital in 2026. Bexalon Management Consultant Reinhard Muller explains why the 60/40 strategy is dead and how gold, commodities, and digital assets can beat inflation.

Host: Sarah Jenkins, Senior Financial Correspondent

Guest: Reinhard Muller, Management Consultant at Bexalon

Sarah Jenkins: For forty years, we've relied on a simple trick: put 60% in stocks, 40% in bonds, and sleep soundly. But in 2026, that "magic" feels more like a trap. Inflation has stabilized on paper, yet real-world costs continue to climb. Reinhard, let's be blunt-is the 60/40 portfolio officially dead, or is it just in a coma?

Reinhard Muller: Sarah, it's not just dead; it's become dangerous. We are living through "Inflation 2.0." Bonds no longer protect the portfolio when stocks fall-instead, they've started moving in lockstep. If you're still clinging to 60/40, you're essentially bringing a kitchen knife to a modern drone fight. At Bexalon, we moved past this foundation long ago, replacing it with dynamic asset allocation.

Sarah Jenkins: Since bonds are no longer the bunker they once were, everyone has retreated to the oldest asset in history. Gold recently smashed through all-time highs again. Is this a genuine safe haven, or are we witnessing a massive, shiny bubble?

Reinhard Muller: It's not a bubble; it's a global "vote of no confidence" in fiat currency stability. Central banks are hoarding gold at record speeds, diversifying away from the dollar. At Bexalon, we don't view gold as a speculation-it's an insurance policy. You don't cancel your home insurance just because the premium went up, do you?

Sarah Jenkins: Fair point. But let's talk about "the new gold." You've integrated crypto-assets directly into the Bexalon infrastructure. How do you justify that to a conservative client who sees "crypto" as synonymous with risk?

Reinhard Muller: We are talking about institutional-grade digital assets. For us, Bitcoin or Ethereum are non-correlated instruments. When the traditional system faces friction, digital assets move on different "rails." We simply provide our clients with access to these alternative paths so that a systemic crisis doesn't wipe out their entire capital at once.

Sarah Jenkins: You are also betting big on commodities-copper, lithium, agricultural products. Why is "stuff" becoming the "third pillar" of the portfolio in this decade?

Reinhard Muller: Because you can't print a copper mine. The world needs physical materials for AI and the green energy transition. For a decade, we invested in "bits"-software and apps. Now, the world has realized we neglected "atoms." Commodities are the only asset class that grows alongside the very drivers of inflation.

Sarah Jenkins: What about cash? We used to say "Cash is trash." In 2026, is that still true?

Reinhard Muller: Cash is trash only when it sits idle. Today, cash is your "ammunition." At Bexalon, we advise keeping a specific percentage in liquidity, not for accumulation, but to have the firepower to enter the market when panic hits. The ability to buy a distressed asset in seconds is a luxury that only cash provides.

Sarah Jenkins: Let's shift geography. Everyone is watching the U.S., but where are the "hidden champions" of growth this year?

Reinhard Muller: India, Southeast Asia, and Latin America. We are seeing a colossal shift in manufacturing. At Bexalon, we are increasingly shifting our focus toward countries that own real resources. The overvalued tech sector of Silicon Valley is yielding ground to the "real economy" in emerging markets.

Sarah Jenkins: Artificial Intelligence. In 2026, is it still hype or a real tool for the investor?

Reinhard Muller: It's a powerful filter. There is so much information noise now that the human brain simply cannot cope. At Bexalon, we use AI to analyze thousands of reports in seconds to find anomalies. AI is your co-pilot, but a human must always stay at the controls when it comes to the final trade.

Sarah Jenkins: Many are concerned about Central Bank Digital Currencies (CBDCs). Could this be the end of financial privacy?

Reinhard Muller: It's a double-edged sword. It offers control for states, but incredible speed for users. Our task at Bexalon is to build bridges. The client must have a choice: use government digital systems for convenience or move into decentralized assets to protect their privacy.

Sarah Jenkins: Real estate was always a classic "safe haven." But the rules have changed. Where should we look now?

Reinhard Muller: City-center offices are a thing of the past. E-commerce warehouses and data centers are the "gold mines" of 2026. If you want to invest in property today, invest in infrastructure. We help clients find funds that own the land underneath cloud storage facilities. That is the most stable "rent" of the modern era.

Sarah Jenkins: One last question, Reinhard. What is the main advice you would give your children regarding money in this unpredictable world?

Reinhard Muller: I tell them: "Don't collect numbers; collect opportunities." In an "Inflation 2.0" world, nominal wealth is an illusion. Invest in your education, in your understanding of technology, and in assets that cannot be simply printed or deleted with a single button. The winner is the one who can pivot their strategy on the fly, and that is exactly the mindset we teach our clients at Bexalon.

Sarah Jenkins: On that note, we'll wrap up. We've been speaking with Reinhard Muller-the man who knows how to make "atoms and bits" work for your capital. Thank you, Reinhard!

Reinhard Muller: Always a pleasure, Sarah.

Official Website: www.bexalon.com [https://www.bexalon.com/]

Address:

Baarerstrasse 14 / 2nd floor, 6300 Zug, Switzerland.

53 Bd Royal, 2449 Ville-Haute, Luxembourg.

Media Contact
Company Name: Bexalon
Contact Person: Support
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-death-of-6040-a-deep-dive-with-reinhard-mller-on-navigating-inflation-20]
Country: Switzerland
Website: http://bexalon.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Death of 60/40: A Deep Dive with Reinhard Muller on Navigating "Inflation 2.0" here

News-ID: 4360647 • Views:

More Releases from ABNewswire

22q11.2 Deletion Syndrome Market Set for Growth Through 2034, with the US Leading Demand and 185+ Associated Conditions Shaping Unmet Clinical Needs | DelveInsight
22q11.2 Deletion Syndrome Market Set for Growth Through 2034, with the US Leadin …
22q11.2 Deletion Syndrome Companies are Zynerba Pharmaceuticals, Inc., Nobias Therapeutics, Inc., Bausch Health Americas, Inc., and others. The United States represents the largest 22q11.2 deletion syndrome market compared with EU4, the United Kingdom, and Japan. The disorder is the most common chromosomal microdeletion in humans and is also known as DiGeorge syndrome and velocardiofacial syndrome. It is caused by a missing segment on chromosome 22q11.2, typically occurring as a de novo
Huntington's Disease Market Poised for Transformation Through Gene Therapies and RNA-Targeted Innovations, with the US Accounting for Over 70% of Global Opportunity | DelveInsight Forecast 2034
Huntington's Disease Market Poised for Transformation Through Gene Therapies and …
Huntington's Disease Clinical Trial Companies are Teva Pharmaceutical, Annexon Biosciences, Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others The United States dominates the Huntington's disease market, accounting for over 70% of the total market size across the seven major markets (7MM). Huntington's disease is a rare, inherited, progressive
Psoriatic Arthritis Market Outlook 2034: 7MM Epidemiology, 30+ Key Companies, and Next-Gen IL-17 & TYK2 Therapies Uncovered by DelveInsight
Psoriatic Arthritis Market Outlook 2034: 7MM Epidemiology, 30+ Key Companies, an …
Psoriatic Arthritis companies working in the market are UCB Biopharma, Sun Pharmaceutical Industries Limited, BMS, Affibody AB, Janssen Biotech, Amgen, Eli Lilly and Company, Teva Pharma, Boehringer Ingelheim, AbbVie, Roche, Ampio Pharmaceuticals, Antares Pharma, Currax Pharmaceuticals, GlaxoSmithKline, Bayer, Sanofi, Astrazeneca, Johnson & Johnson Services, Pfizer and others. The psoriatic arthritis (PsA) treatment market landscape features established therapies such as HUMIRA, OTEZLA, COSENTYX, CIMZIA, and BIMZELX. Alongside these, several promising late-stage candidates-including
Office Plantscape Services Company in Campbell, CA, Celebrates Four Decades of Transforming Silicon Valley Commercial Workspaces
Office Plantscape Services Company in Campbell, CA, Celebrates Four Decades of T …
Campbell, CA - Greenworks Inc., a locally owned and operated business, is celebrating 35 years of bringing life and vibrancy to commercial workspaces throughout Silicon Valley. Since 1991, the company has been serving businesses across seven Bay Area counties: Alameda, Contra Costa, Monterey, Napa, Santa Clara, Santa Cruz, and San Mateo. As a proud 100% women-owned business, Greenworks Inc. has built a reputation for excellence in creating healthier, more productive

All 5 Releases


More Releases for Reinhard

ZIWI Peak Appoints Clark Reinhard as New President, North America
September 18, 2024 - Overland Park, Kansas - ZIWI [https://us.ziwipets.com/], a leader in premium pet nutrition, is pleased to announce the appointment of Clark Reinhard as the new President for North America. Reinhard brings with him a wealth of experience in FMCG leadership, having previously held key roles at Wellness Pet Company, Ocean Spray Registered , and Procter & Gamble. Reinhard succeeds Mary Helen Horn, who departed ZIWI in July after
Artificial Urinary Sphincter Market Size, 2023 Analysis, Industry Trends and For …
"Artificial Urinary Sphincter Market" In this report, thorough SWOT analysis & investment analysis is provided which forecasts imminent opportunities for the Artificial Urinary Sphincter Market players shared by Infinitybusinessinsights.com. This report will help the viewer in Better Decision Making. The global artificial urinary sphincter market was valued at USD 377 million in 2023 and is predicted to increase at an 8.2% CAGR from 2023 to 2030. The Artificial Urinary Sphincter (AUS)
Artificial Urinary Sphincter Market Innovations and Growth Prospects 2023-2030 | …
Infinitybusinessinsights.com shared report "Artificial Urinary Sphincter Market" which covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Artificial Urinary Sphincter Market. This report will help the viewer in Better Decision Making. From 2023 to 2030, the Artificial Urinary Sphincter Market is projected to increase at a compound
Artificial Urinary Sphincter Market Share 2022 Growth Challenges, Opportunities …
The Artificial Urinary Sphincter document gathers sizeable statistics of the vital problem market gamers in the company, which encompass market individuals, unrefined substance carriers, hardware providers, forestall customers, sellers, wholesalers, and others. The market measurements and records have been acquired from reliable resources like websites, each analysis of businesses, diaries, and specific distributions, then, at that factor, twofold checked and time-honoured with the aid of business enterprise specialists. Current realities
Artificial Urinary Sphincter Market Comprehensive Report 2017 – 2027: Analysis …
Artificial urinary sphincter is a device which is composed of silicone rubber that is preferred for the treatment of urinary incontinence. Urinary sphincter is a muscle which controls the flow of urine through your bladder. Artificial urinary sphincter (AUS) is used to control the flow of urine and is most commonly used in men. It is designed to supplement the function of natural urinary sphincter which restricts the urine flow
15.11.12 at Galerie BLAUE STUNDE in Berlin // 3 Formate - Video, Sculpture & Abs …
Berlin, November 2012. Gallery BLAUE STUNDE is pleased to present works from various disciplines at the new exhibition '3 Formate'. From 15 November 2012 to 10 January 2013 works from artists Astrid Högner, Reinhard Haverkamp and Eeva Hauss will be shown, which approach the theme of movement each in their own artistic elaboration. Abstract painting by Eeva Hauss meets the wooden and metal sculptures of Reinhard Haverkamp. For both artists the subject